共 50 条
- [1] A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLLLeukemia, 2010, 24 : 1972 - 1975J R Brown论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyJ Abramson论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyE Hochberg论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyE Mikler论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyV Dalton论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyL Werner论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyH Reynolds论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyC Thompson论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyS M McDonough论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyY Kuang论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyJ Ritz论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyD Neuberg论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyA S Freedman论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical Oncology
- [2] A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLLLEUKEMIA, 2010, 24 (11) : 1972 - 1975Brown, J. R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Univ, Sch Med, Dept Med, Boston, MA USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAAbramson, J.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dept Med, Boston, MA USA Massachusetts Gen Hosp, Dept Med, Div Oncol, Boston, MA 02114 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAHochberg, E.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dept Med, Boston, MA USA Massachusetts Gen Hosp, Dept Med, Div Oncol, Boston, MA 02114 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMikler, E.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USADalton, V.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAWerner, L.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAReynolds, H.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAThompson, C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMcDonough, S. M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAKuang, Y.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Ctr Clin & Translat Res, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USARitz, J.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Univ, Sch Med, Dept Med, Boston, MA USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Freedman, A. S.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Univ, Sch Med, Dept Med, Boston, MA USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
- [3] A phase Ib/II study of duvelisib in combination with FCR (dFCR) in previously untreated, younger patients with CLLLEUKEMIA & LYMPHOMA, 2017, 58 : 225 - 225Davids, Matthew S.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAKim, Haesook T.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAHanna, John论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USACowen, Leslie论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAFrancoeur, Karen论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAHellman, Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAArnason, Jon论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Dana Farber Canc Inst, Boston, MA 02115 USAOdejide, Oreofe论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAArmand, Philippe论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Brown, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USA
- [4] Combination chemotherapy with fludarabine, cyclophosphamide and mitoxantrone (FCM) induces a high response rate in previously untreated CLLANNALS OF ONCOLOGY, 2005, 16 : 43 - 43Bosch, F论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainFerrer, A论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainVillamor, N论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainGonzález, M论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainEscoda, L论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainAsensi, A论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainAbella, M论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainGonzález-Barca, E论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainGardella, S论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainGiné, E论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainMuntañola, A论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainSayas, M论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainPérez-Ceballos, E论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainBesalduch, J论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, SpainMontserrat, E论文数: 0 引用数: 0 h-index: 0机构: GELCAB, Barcelona, Spain GELCAB, Barcelona, Spain
- [5] A Phase I Study of Lenalidomide in Combination with Fludarabine-Rituximab in Previously Untreated CLL/SLL.BLOOD, 2009, 114 (22) : 1330 - 1331Brown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAAbramson, Jeremy S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Ctr Lymphoma, Boston, MA USA Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAHochberg, Ephraim P.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Ctr Lymphoma, Newton, MA USA Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAMikler, Evgeny论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USADalton, Virginia论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAReynolds, Hazel论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USARomano, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAWerner, Lillian论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAThompson, Christina论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAMcDonough, Sean论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USARitz, Jerome论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Canc Vaccine Ctr,Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USANeuberg, Donna论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USAFreedman, Arnold S.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Biostat & Computat Biolog, Boston, MA 02115 USA
- [6] Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLLBLOOD, 2011, 118 (21) : 1665 - 1666Shanafelt, Tait D.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USALanasa, Mark C.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Mayo Clin, Div Hematol, Rochester, MN USAZent, Clive S.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USALeis, Jose F.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Div Hematol & Med Oncol, Scottsdale, AZ USA Mayo Clin, Div Hematol, Rochester, MN USACall, Timothy G.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USALaPlant, Betsy R.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USATun, Han论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Jacksonville, Jacksonville, FL 32224 USA Mayo Clin, Div Hematol, Rochester, MN USABowen, Deborah A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USAJelinek, Diane F.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Dept Immunol, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USAHanson, Curtis A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematopathol, Dept Lab Med, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USAKay, Neil论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA Mayo Clin, Div Hematol, Rochester, MN USA
- [7] Combination chemotherapy with fludarabine, cyclophosphamide and mitoxantrone (FCM) induces a high response rate in previously untreated CLL.BLOOD, 2005, 106 (11) : 213A - 213ABosch, F论文数: 0 引用数: 0 h-index: 0Ferrer, A论文数: 0 引用数: 0 h-index: 0Villamor, N论文数: 0 引用数: 0 h-index: 0Gine, E论文数: 0 引用数: 0 h-index: 0Abella, MA论文数: 0 引用数: 0 h-index: 0Gardella, S论文数: 0 引用数: 0 h-index: 0Besalduch, J论文数: 0 引用数: 0 h-index: 0Gonzalez, M论文数: 0 引用数: 0 h-index: 0Altes, A论文数: 0 引用数: 0 h-index: 0Escoda, L论文数: 0 引用数: 0 h-index: 0Ferrer, S论文数: 0 引用数: 0 h-index: 0Gonzalez-Barca, E论文数: 0 引用数: 0 h-index: 0Perez-Ceballos, E论文数: 0 引用数: 0 h-index: 0Asensi, A论文数: 0 引用数: 0 h-index: 0Montserrat, E论文数: 0 引用数: 0 h-index: 0
- [8] Combination of Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with CLL: A Pilot Phase II StudyBLOOD, 2017, 130Ahn, Inhye E.论文数: 0 引用数: 0 h-index: 0Soto, Susan论文数: 0 引用数: 0 h-index: 0Nierman, Pia论文数: 0 引用数: 0 h-index: 0Tian, Xin论文数: 0 引用数: 0 h-index: 0Valdez, Janet论文数: 0 引用数: 0 h-index: 0Lotter, Jennifer论文数: 0 引用数: 0 h-index: 0Fleisher, Thomas论文数: 0 引用数: 0 h-index: 0Rosenzweig, Sergio论文数: 0 引用数: 0 h-index: 0Rampertaap, Shakuntala论文数: 0 引用数: 0 h-index: 0Maric, Irina论文数: 0 引用数: 0 h-index: 0Stetler-Stevenson, Maryalice论文数: 0 引用数: 0 h-index: 0Yuan, Constance论文数: 0 引用数: 0 h-index: 0Marti, Gerald论文数: 0 引用数: 0 h-index: 0Wiestner, Adrian论文数: 0 引用数: 0 h-index: 0
- [9] Preliminary results of a phase Ib study of duvelisib in combination with FCR (dFCR) in previously untreated, younger patients with CLLLEUKEMIA & LYMPHOMA, 2015, 56 : 19 - 19论文数: 引用数: h-index:机构:Kim, Haesook T.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USAGilbert, Elizabeth论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USACowen, Leslie论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USAFrancoeur, Karen论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USAHellman, Jeffrey M.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USAArnason, Jon E.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USAFisher, David C.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USABrown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Dana Farber Canc Inst, Boston, MA USA Harvard Univ, Dana Farber Canc Inst, Boston, MA USA
- [10] Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre StudyBLOOD, 2014, 124 (21)Gentile, Massimo论文数: 0 引用数: 0 h-index: 0机构: Osped Annunziata, Cosenza, Italy Osped Annunziata, Cosenza, ItalyCiolli, Stefania论文数: 0 引用数: 0 h-index: 0机构: Univ Florence, Florence, Italy Osped Annunziata, Cosenza, ItalyMolica, Stefano论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Pugliese Ciaccio, Catanzaro, Italy Osped Annunziata, Cosenza, ItalyDi Renzo, Nicola论文数: 0 引用数: 0 h-index: 0机构: Osped Vito Fazzi, Lecce, Italy Osped Annunziata, Cosenza, ItalySelleri, Carmine论文数: 0 引用数: 0 h-index: 0机构: Univ Salerno, I-84100 Salerno, Italy Osped Annunziata, Cosenza, ItalyVilla, Maria Rosaria论文数: 0 引用数: 0 h-index: 0机构: UOC Ematol PO San Gennaro Napoli, Naples, Italy Osped Annunziata, Cosenza, ItalyDe Paolis, Maria Rosaria论文数: 0 引用数: 0 h-index: 0机构: Osped Lecce, Lecce, Italy Osped Annunziata, Cosenza, ItalyScortechini, Ilaria论文数: 0 引用数: 0 h-index: 0机构: Osped Riuniti Ancona, Ancona, Italy Osped Annunziata, Cosenza, ItalyGiannotta, Angela论文数: 0 引用数: 0 h-index: 0机构: UOC Ematol Osped Antonio Perrino Brindisi, Brindisi, Italy Osped Annunziata, Cosenza, ItalyMinoia, Carla论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Res Ctr, Haematol Unit, Bari, Italy Osped Annunziata, Cosenza, ItalyRago, Angela论文数: 0 引用数: 0 h-index: 0机构: Polo Univ Pontino, Dept Hematol, Latina, Italy Osped Annunziata, Cosenza, ItalyBoncompagni, Riccardo论文数: 0 引用数: 0 h-index: 0机构: Univ Florence, Florence, Italy Osped Annunziata, Cosenza, ItalyBonanno, Vincenza论文数: 0 引用数: 0 h-index: 0机构: UO Ematol & Trapianto Midollo Osseo, Palermo, Italy Osped Annunziata, Cosenza, ItalyLevato, Luciano论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Pugliese Ciaccio, Catanzaro, Italy Osped Annunziata, Cosenza, ItalyMusso, Maurizio论文数: 0 引用数: 0 h-index: 0机构: La Maddalena, Dept Oncol, Palermo, Italy Osped Annunziata, Cosenza, ItalyMastrullo, Lucia论文数: 0 引用数: 0 h-index: 0机构: Osped S Gennaro S Giovanni Bosco, Naples, Italy Osped Annunziata, Cosenza, ItalyMelpignano, Angela论文数: 0 引用数: 0 h-index: 0机构: Osped A Perrino, Brindisi, Italy Osped Annunziata, Cosenza, ItalyMurru, Roberta论文数: 0 引用数: 0 h-index: 0机构: UO Ematol & CTMO Osped Oncol A Businco, Cagliari, Italy Osped Annunziata, Cosenza, ItalyAngelucci, Emanuele论文数: 0 引用数: 0 h-index: 0机构: UO Ematol & CTMO Osped Oncol A Businco, Cagliari, Italy Osped Annunziata, Cosenza, ItalyTarantini, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: UOC Ematol Osped Dimiccoli Barletta, Barletta, Italy Osped Annunziata, Cosenza, ItalyCaparrotti, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: ASL CE PO, Aversa, Italy Osped Annunziata, Cosenza, ItalyGuarini, Attilio论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Res Ctr Ist Tumori, Bari, Italy Osped Annunziata, Cosenza, ItalyFerrara, Felicetto论文数: 0 引用数: 0 h-index: 0机构: Cardarelli Hosp, Naples, Italy Osped Annunziata, Cosenza, ItalyCimino, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: Univ Roma La Sapienza, I-00185 Rome, Italy Osped Annunziata, Cosenza, ItalyZinzani, Pier Luigi论文数: 0 引用数: 0 h-index: 0机构: Univ Bologna, Bologna, Italy Osped Annunziata, Cosenza, ItalyMorabito, Fortunato论文数: 0 引用数: 0 h-index: 0机构: Hosp Cosenza, Dept Oncohematol, Hematol Unit, Cosenza, Italy Osped Annunziata, Cosenza, Italy